Published in Eur J Nucl Med Mol Imaging on May 25, 2016
Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease. Yonsei Med J (2017) 0.75
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease. J Neurol (2017) 0.75
Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation. Eur Arch Otorhinolaryngol (2017) 0.75
A default mode of brain function. Proc Natl Acad Sci U S A (2001) 50.73
Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A (2002) 31.14
The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci (2008) 29.64
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage (2003) 24.48
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A (2004) 19.84
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp (2000) 15.98
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci (2005) 12.85
Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex (2008) 9.38
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci (2007) 7.96
Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp (2005) 4.11
Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet (2006) 3.94
Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp (1997) 3.23
Investigating the functional heterogeneity of the default mode network using coordinate-based meta-analytic modeling. J Neurosci (2009) 3.21
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition. Proc Natl Acad Sci U S A (2010) 2.80
Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space. Neuroimage (1999) 2.62
Default mode network connectivity in stable vs progressive mild cognitive impairment. Neurology (2011) 2.44
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging (2009) 2.15
Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology (2011) 1.75
Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet (2011) 1.75
The principled control of false positives in neuroimaging. Soc Cogn Affect Neurosci (2009) 1.70
Intercorrelations of glucose metabolic rates between brain regions: application to healthy males in a state of reduced sensory input. J Cereb Blood Flow Metab (1984) 1.51
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease. Neurobiol Aging (2010) 1.35
Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage (2003) 1.33
Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid Redox Signal (2007) 1.28
Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochim Biophys Acta (2011) 1.16
Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. Eur J Nucl Med Mol Imaging (2008) 1.15
PET studies in dementia. Ann Nucl Med (2003) 1.09
From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease. Mol Neurobiol (2012) 1.07
Dynamic brain functional connectivity modulated by resting-state networks. Brain Struct Funct (2015) 1.03
Attention-related networks in Alzheimer's disease: a resting functional MRI study. Hum Brain Mapp (2011) 1.02
Characteristics of the default mode functional connectivity in normal ageing and Alzheimer's disease using resting state fMRI with a combined approach of entropy-based and graph theoretical measurements. Neuroimage (2014) 0.95
Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease. Cereb Cortex (2014) 0.94
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses. Neuroimage (2012) 0.92
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. J Neural Transm Suppl (2007) 0.91
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics (2014) 0.91
Ratio of Aβ42/P-tau181p in CSF is associated with aberrant default mode network in AD. Sci Rep (2013) 0.90
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting. Neuroimage Clin (2014) 0.89
Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage (2002) 0.87
Effects of brain amyloid deposition and reduced glucose metabolism on the default mode of brain function in normal aging. J Neurosci (2011) 0.87
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. Eur J Nucl Med Mol Imaging (2015) 0.85
Whole cortical and default mode network mean functional connectivity as potential biomarkers for mild Alzheimer's disease. Psychiatry Res (2013) 0.83
Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology (1998) 0.82
CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2014) 0.81
Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease. Neurosci Lett (1995) 0.81
Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study. Nucl Med Commun (2015) 0.79
Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer's disease and other dementias. J Alzheimers Dis (2014) 0.79
Brain metabolic changes in Hodgkin disease patients following diagnosis and during the disease course: An (18)F-FDG PET/CT study. Oncol Lett (2014) 0.79
Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology (2000) 0.76
Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease. Arch Gerontol Geriatr (2015) 0.75
Diagnostic accuracy of blood and CSF lactate in identifying children with mitochondrial diseases affecting the central nervous system. Brain Dev (2011) 0.75
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. J Neural Transm (Vienna) (2017) 0.75
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease. J Neurol (2017) 0.75